Acadia Pharmaceuticals Inc

Ownership Transactions Reported by 18 Insiders

Symbol
ACAD on Nasdaq
Location
12830 El Camino Real, Suite 400, San Diego, CA

Insiders trading volume in the past year

Acadia Pharmaceuticals Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Baker Bros. Advisors Lp Director, 10%+ Owner $688M May 29, 2025
Stephen Davis CEO, Director $4.05M Aug 16, 2024
Srdjan R. Stankovic President $1.83M Nov 19, 2022
E. Owen Chief Executive Officer, Director $1.71M Mar 24, 2025
Douglas J. Williamson Executive VP, Research & Dev $1.52M Feb 10, 2023
Austin D. Kim EVP,General Counsel, Secretary $1.41M Jan 6, 2024
Brendan Teehan Evp, Coo, Head Of Commercial $1.21M -$174K -12.5% Nov 17, 2024
Mark C. Schneyer Evp, Chief Financial Officer $1.09M -$1.02M -48.4% Sep 12, 2025
Daniel B. Soland Director $927K May 29, 2025
Elizabeth A. Garofalo Director $818K -$131K -13.8% Sep 2, 2025
Edmund Harrigan Director $770K May 29, 2025
Thomas Garner EVP, Chief Commercial Officer $763K Dec 9, 2024
James M. Daly Director $753K May 29, 2025
Jennifer J. Rhodes Evp, Chief Legal Officer, Sec $567K Mar 24, 2025
H.Z. Thompson EVP, Head of Research & Dev $490K Mar 24, 2025
Laura Brege Director $488K -$315K -39.2% Jun 4, 2025
James Kihara Principal Accounting Officer $442K -$221K -33.3% May 16, 2025
Adora Ndu Director $433K May 29, 2025

Recent Insider Transactions by Companies or Individuals for Acadia Pharmaceuticals Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.